Subtopic Deep Dive
LXR-Mediated Cholesterol Efflux
Research Guide
What is LXR-Mediated Cholesterol Efflux?
LXR-mediated cholesterol efflux is the process by which liver X receptors (LXRs) sense intracellular cholesterol levels and induce expression of ABCA1 and ABCG1 transporters to promote cholesterol efflux to HDL from macrophages and hepatocytes.
Liver X receptors (LXRα and LXRβ) act as oxysterol sensors that transcriptionally activate ABCA1/G1 for reverse cholesterol transport (Chawla et al., 2001; Repa et al., 2000). This pathway counters foam cell formation in atherosclerosis but synthetic LXR agonists cause hypertriglyceridemia via SREBP-1c induction (Schultz et al., 2000). Over 10 key papers from 1998-2004, cited >10,000 times collectively, define this mechanism.
Why It Matters
LXR-mediated efflux elevates HDL to reduce atherosclerotic plaque in macrophages, as shown in PPARγ-LXR-ABCA1 pathway studies preventing atherogenesis (Chawla et al., 2001). LXRs regulate lipogenesis via SREBP-1c, explaining agonist-induced triglycerides that limit clinical use (Repa et al., 2000; Schultz et al., 2000). Targeting this pathway offers therapies for cardiovascular disease, with LXR knockout mice displaying impaired cholesterol metabolism (Peet et al., 1998).
Key Research Challenges
Hypertriglyceridemic Side Effects
Synthetic LXR agonists promote cholesterol efflux via ABCA1 but induce SREBP-1c-driven lipogenesis and hypertriglyceridemia (Schultz et al., 2000). This limits therapeutic dosing in atherosclerosis models. Selective LXR modulators are needed to dissociate benefits from lipid elevation (Repa et al., 2000).
Tissue-Specific LXR Regulation
LXRs control efflux in macrophages and hepatocytes differently, with LXRα knockout impairing bile acid synthesis but not macrophage efflux (Peet et al., 1998). Balancing intestine, liver, and macrophage activities remains challenging. Isoform-specific agonists could improve outcomes (Chawla et al., 2001).
Endogenous Ligand Identification
Oxysterols activate LXRs to regulate cholesterol homeostasis, but precise physiological ligands and sensors need clarification (Repa et al., 2000). Genetic models show incomplete phenocopy without full ligand context. This hinders agonist design mimicking natural activation (Chawla et al., 2001).
Essential Papers
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Jay D. Horton, Joseph L. Goldstein, Michael S. Brown · 2002 · Journal of Clinical Investigation · 3.9K citations
Lipid homeostasis in vertebrate cells is regulated by a family of membrane-bound transcription factors designated sterol regulatory element-binding proteins (SREBPs).SREBPs directly activate the ex...
Atherosclerosis
Christopher K. Glass, Joseph L. Witztum · 2001 · Cell · 3.0K citations
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Ajay Chawla, Joyce J. Repa, Ronald M. Evans et al. · 2001 · Science · 2.1K citations
Cholesterol, fatty acids, fat-soluble vitamins, and other lipids present in our diets are not only nutritionally important but serve as precursors for ligands that bind to receptors in the nucleus....
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Michael Dean, Andrey Rzhetsky, Rando Allikmets · 2001 · Genome Research · 1.7K citations
The ATP-binding cassette (ABC) transporter superfamily contains membrane proteins that translocate a variety of substrates across extra- and intra-cellular membranes. Genetic variation in these gen...
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
Joyce J. Repa, Guosheng Liang, Jiafu Ou et al. · 2000 · Genes & Development · 1.7K citations
The liver X receptors (LXRs) are members of the nuclear hormone receptor superfamily that are bound and activated by oxysterols. These receptors serve as sterol sensors to regulate the transcriptio...
Role of LXRs in control of lipogenesis
Joshua R. Schultz, Hua Tu, Alvin Luk et al. · 2000 · Genes & Development · 1.7K citations
The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol meta...
Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα
Daniel J. Peet, Stephen D. Turley, Wenzhen Ma et al. · 1998 · Cell · 1.4K citations
Reading Guide
Foundational Papers
Start with Repa et al. (2000) for LXR sterol sensor mechanism and SREBP-1c regulation, then Peet et al. (1998) for LXRα knockout cholesterol phenotypes establishing efflux necessity.
Recent Advances
Chawla et al. (2001) integrates PPARγ-LXR-ABCA1 in macrophages; Schultz et al. (2000) details lipogenesis control critical for agonist side effects.
Core Methods
Oxysterol activation assays, LXR knockout mice, ABCA1 expression qPCR, synthetic agonists like T0901317, HDL efflux measurements in macrophages (Repa et al., 2000; Schultz et al., 2000).
How PapersFlow Helps You Research LXR-Mediated Cholesterol Efflux
Discover & Search
Research Agent uses citationGraph on 'Regulation of mouse SREBP-1c by LXRα/β' (Repa et al., 2000) to map LXR networks connecting to ABCA1 efflux papers like Chawla et al. (2001), then findSimilarPapers uncovers related oxysterol sensor studies. exaSearch queries 'LXR agonists hypertriglyceridemia mechanisms' for 50+ hits beyond OpenAlex.
Analyze & Verify
Analysis Agent applies readPaperContent to Schultz et al. (2000) for LXR lipogenesis data, then runPythonAnalysis on extracted dose-response curves with pandas to quantify triglyceride induction vs. efflux. verifyResponse with CoVe cross-checks claims against Peet et al. (1998) LXRα knockout, graded via GRADE for high evidence on cholesterol impairment.
Synthesize & Write
Synthesis Agent detects gaps in selective LXR modulator efficacy via contradiction flagging between Repa et al. (2000) and Chawla et al. (2001), then Writing Agent uses latexEditText and latexSyncCitations to draft pathway reviews citing 20+ papers, with latexCompile for figures and exportMermaid for LXR-ABCA1-HDL diagrams.
Use Cases
"Extract cholesterol efflux rates from LXR agonist experiments in Repa et al. 2000 and plot vs. controls"
Research Agent → searchPapers('Repa LXR SREBP') → Analysis Agent → readPaperContent → runPythonAnalysis(pandas/matplotlib dose-response plot) → researcher gets CSV-exported graphs with statistical p-values.
"Write LaTeX review on LXR-ABCA1 pathway with citations from Chawla 2001 and Schultz 2000"
Synthesis Agent → gap detection → Writing Agent → latexEditText(draft section) → latexSyncCitations(20 papers) → latexCompile(PDF) → researcher gets compiled review with synced Horton et al. (2002) refs.
"Find GitHub repos analyzing LXR knockout mouse data from Peet et al. 1998"
Research Agent → citationGraph(Peet 1998) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets repo links with scripts for bile acid/cholesterol stats.
Automated Workflows
Deep Research workflow scans 50+ LXR papers via searchPapers → citationGraph → structured report on efflux vs. lipogenesis tradeoffs, checkpointed with CoVe. DeepScan applies 7-step analysis to Chawla et al. (2001): readPaperContent → verifyResponse → runPythonAnalysis on ABCA1 expression data. Theorizer generates hypotheses on isoform-selective agonists from Repa et al. (2000) + Schultz et al. (2000) contradictions.
Frequently Asked Questions
What defines LXR-mediated cholesterol efflux?
LXRs sense oxysterols to induce ABCA1/G1 expression, driving cholesterol efflux to HDL from macrophages/hepatocytes (Repa et al., 2000; Chawla et al., 2001).
What are key methods in LXR studies?
Mouse knockouts reveal phenotypes like impaired bile acid synthesis in LXRα-/- (Peet et al., 1998); synthetic agonists test lipogenesis via SREBP-1c (Schultz et al., 2000).
What are seminal papers on this topic?
Repa et al. (2000, 1676 cites) shows LXRs regulate SREBP-1c; Chawla et al. (2001, 1325 cites) links PPARγ-LXR-ABCA1 to atherogenesis prevention.
What are open problems in LXR efflux research?
Developing agonists avoiding hypertriglyceridemia via selective modulation; clarifying tissue-specific roles beyond knockouts (Schultz et al., 2000; Peet et al., 1998).
Research Cholesterol and Lipid Metabolism with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching LXR-Mediated Cholesterol Efflux with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cholesterol and Lipid Metabolism Research Guide